tiprankstipranks
Advertisement
Advertisement

REGN Stock Latest News

J&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital
The FlyJ&J, Bristol-Myers face negotiation risk under new CMS rule, says RBC Capital
2d ago
BMY
JNJ
Regeneron Tests Weekly Praluent Dosing in New Cholesterol Study: What Investors Should Watch
PremiumCompany Announcements
Regeneron Tests Weekly Praluent Dosing in New Cholesterol Study: What Investors Should Watch
7d ago
REGN
RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge
PremiumCompany Announcements
RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge
13d ago
REGN
CytomX Therapeutics expands licensing agreement with Regeneron
PremiumThe Fly
CytomX Therapeutics expands licensing agreement with Regeneron
14d ago
CTMX
REGN
Regeneron’s CLIO-1 Update: What a Completed Early Lymphoma Trial Means for REGN Investors
PremiumCompany Announcements
Regeneron’s CLIO-1 Update: What a Completed Early Lymphoma Trial Means for REGN Investors
15d ago
REGN
Regeneron Steps Into CAR T for Advanced Prostate Cancer With New Phase 1 Trial
PremiumCompany AnnouncementsRegeneron Steps Into CAR T for Advanced Prostate Cancer With New Phase 1 Trial
19d ago
REGN
Regeneron Expands Into Pulmonary Hypertension With New Phase 2 Trial for REGN13335
Premium
Company Announcements
Regeneron Expands Into Pulmonary Hypertension With New Phase 2 Trial for REGN13335
19d ago
REGN
Regeneron Targets Stroke Prevention Gap With New Atrial Fibrillation Trial
Premium
Company Announcements
Regeneron Targets Stroke Prevention Gap With New Atrial Fibrillation Trial
19d ago
REGN
Regeneron Advances Phase 3 ROXI-CAT-II Trial, Targeting Safer Cancer-Related Clot Treatment
PremiumCompany Announcements
Regeneron Advances Phase 3 ROXI-CAT-II Trial, Targeting Safer Cancer-Related Clot Treatment
19d ago
REGN
Regeneron Ebola antibody recommended by WHO for investigational use
PremiumThe Fly
Regeneron Ebola antibody recommended by WHO for investigational use
20d ago
REGN
Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
PremiumWeekend Updates
Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts
25d ago
PBA
BURL
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
PremiumCompany Announcements
Regeneron’s ROXI-PALISADE Trial Targets Safer Clot Prevention in Peripheral Artery Disease
26d ago
REGN
Regeneron says EMA accepted review under AA the MAA for Otarmeni
PremiumThe FlyRegeneron says EMA accepted review under AA the MAA for Otarmeni
26d ago
REGN
Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension
Premium
Company Announcements
Regeneron’s REGN7544 Trial Reaches Key Milestone in Sepsis-Induced Hypotension
28d ago
REGN
Regeneron price target lowered to $875 from $1,057 at Canaccord
Premium
The Fly
Regeneron price target lowered to $875 from $1,057 at Canaccord
29d ago
REGN
Regeneron price target lowered to $860 from $900 at Wolfe Research
PremiumThe Fly
Regeneron price target lowered to $860 from $900 at Wolfe Research
30d ago
REGN
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
PremiumThe Fly
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
1M ago
D
F
Regeneron falls -11.1%
PremiumThe Fly
Regeneron falls -11.1%
1M ago
REGN
Zscaler upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Zscaler upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
1M ago
ZS
ARM
Video: NextEra buying Dominion to form energy giant
PremiumThe FlyVideo: NextEra buying Dominion to form energy giant
1M ago
D
BIO
Morning Movers: LiveRamp jumps following pact to be acquired by Publicis
Premium
The Fly
Morning Movers: LiveRamp jumps following pact to be acquired by Publicis
1M ago
D
F
Regeneron price target lowered to $825 from $875 at Evercore ISI
Premium
The Fly
Regeneron price target lowered to $825 from $875 at Evercore ISI
1M ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >